As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...